Celltrion
068270.KS
#827
Rank
C$40.57 B
Marketcap
C$185.50
Share price
-1.72%
Change (1 day)
22.99%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2025 (TTM): C$1.19 Billion

According to Celltrion 's latest financial reports the company's current earnings are C$2.94 Billion. , an increase over its 2024 earnings that were of C$0.63 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2025

Annual earnings

Year Earnings Change
2025 C$1.17 B84.38%
2024 C$0.63 B-8.89%
2023 C$0.69 B6.61%
2022 C$0.65 B-21.93%
2021 C$0.83 B10.28%
2020 C$0.75 B65.38%
2019 C$0.45 B16.74%
2018 C$0.39 B-33.93%
2017 C$0.59 B106.65%
2016 C$0.28 B25.18%
2015 C$0.23 B-6.4%
2014 C$0.24 B47.49%
2013 C$0.16 B-33.58%
2012 C$0.25 B
2010 C$0.13 B72.52%
2009 C$75.7 M258.3%
2008 C$21.12 M